BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS(TM) Patient
On Jan. 13, 2026, BriaCell Therapeutics announces the durable and sustained complete resolution of a lung metastasis in…
Stem cell engineering breakthrough paves way for next-generation living drugs
On Jan. 8, 2026, for the first time, researchers at the University of British Columbia have demonstrated how…
First human transplant of kidney modified to have ‘universal’ blood type
On Oct. 3, 2025, scientists have converted the blood type of a donor kidney and transplanted the organ…
UBC Faculty of Medicine members receive 2023 Order of British Columbia
On Jun. 5, 2023, the University of British Columbia (UBC) announced that the faculty of medicine’s Drs. John…
Passenger with measles travelled through Vancouver International Airport
On Oct. 29, 2024, the BC Centre for Disease Control announced that travellers were alerted to potential exposure…
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | Vaccine
Passenger with measles travelled through Vancouver International Airport
On Nov. 29, 2023, the BC Centre for Disease Controlr Disease Control (BCCDC) announced that a A passenger…
Biotechnology | Diagnostics | Disease | Medical Device | Medicine | Non-Profit Research | Therapeutics
University of Victoria BioInnovation Hub to enhance collaboration in BC’s life sciences sector
On Aug. 31, 2022, a new front-door to the University of Victoria opened to advance health and life…
University of British Columbia researchers received the New Frontiers in Research Fund 2020 Exploration award
On Jun. 14, 2021, University of British Columbia researchers Dr. Jayachandran Kizhakkedathu, Dr. Caigan Du and Dr. Christopher…
The ALS Society of BC awarded $2 million for PROJECT HOPE to establish ALS research professorship at UBC
On May 12, 2021, the province of British Columbia provided the ALS Society of BC with $2 million…
Biotechnology | Cardiology | Disease | FDA | Therapeutics
FDA approved Aurinia Pharmaceuticals LUPKYNIS (voclosporin) for adults with active lupus nephritis
On Jan. 22, 2021, Aurinia Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved LUPKYNISTM…
Peanut allergy treatment significantly lowered risk of life-threatening reactions in preschoolers
On Dec. 3, 2020, a new study by researchers at the University of British Columbia and BC Children’s…
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Vaccine
University of British Columbia scientists sequence genomes of Canadians with COVID-19
On Jul. 22, 2020, through the Canadian COVID Genomics Network (CanCOGeN) ‘a new initiative was launched by Genome…
Pascal Biosciences discovered a cannabinoid that combats Coronavirus
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
MSFHR funded COVID-19 research to mitigate effects on BC’s vulnerable populations
On Jun. 29, 2020, the Michael Smith Foundation for Health Research (MSFHR) COVID-19 Research Response Fund announced funding…
Government of Canada and provincial partners invested more than $109 mllion in COVID-19 research
On Jun. 25, 2020, the Government of Canada announced the results of that funding competition: an investment of…
University of British Columbia researchers developed biodegradable medical mask for COVID-19
On May 21, 2020, the BioProducts Institute at the University of British Columbia announced it had designed a…
University of British Columbia Professor Amanda Vincent was named the 2020 winner of the Indianapolis Prize
On May 12, 2020, University of British Columbia Professor Amanda Vincent, the first biologist to study seahorses in…
AbCellera identified antibodies for potential use in drugs to treat and prevent COVID-19
On May 3, 2020, AbCellera announced it had received a commitment of up to $175.6 million in support…
Pascal Biosciences discovered cannabinoids activate the major histocompatibility complex to aid cancer treatment
On Sept. 23, 2019, Pascal Biosciences identified specific cannabinoids that enhance the immunogenicity of tumor cells, rendering them…
Canadian Cancer Trials Group announced IND.234 clinical trial using liquid biopsy technology for prostrate cancer screening
On Nov. 27, 2018, the Canadian Cancer Trials Group, a new clinical trial, opened across Canada. This was…
Prime Minister Trudeau announced federal funding for the Institute for Advanced Medical Isotopes
On Nov. 13, 2018, Canadian Prime Minister Justin Trudeau announced federal funding for the Institute for Advanced Medical…
Researchers at JCVI, UCSD, and Scripps Oceanography discovered genetic basis for how harmful algal blooms become toxic
On Sept. 27, 2018, researchers from Scripps Institution of Oceanography at UCSD and the J. Craig Venter Institute…
AbCellera raises $10M for machine-learning fueled antibody discovery platform
On Sept. 27, 2018, AbCellera, a biotech startup based in Vancouver, B.C., announced that it has raised a…
University of British Columbia scientists developed synthetic heart valves
On Sept. 1, 2016, the University of British Columbia (UBC) announced that researchers at UBC’s Okanagan campus had…
Biotechnology | Chemistry | Diagnostics | Disease | Genomics | Therapeutics
BC Children’s Hospital and UBCﾠ researchers discovered precise genetic or biochemical defects in intellectual disabilities
On Jun. 9, 2016, BC Children’s Hospital and the University of British Columbia (UBC) researchers announced that they…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Therapeutics
University of British Columbia researchers discovered a genetic link to multiple sclerosis
On Jun. 1, 2016, scientists at the University of British Columbia and Vancouver Coastal Health announced proof that…
TapImmune announced it’s corporate headquarters relocation from Seattle to Jacksonville Florida
On Nov. 5, 2015, TapImmune, (TPIV) announced it had relocated its corporate headquarters from Seattle, Washington, to Jacksonville,…
Canadian diamond pioneer Charles Fipke donated $9.1 million for Alzheimer’s research at UBC
On Sept. 30, 2014, Canadian diamond pioneer Charles Fipke donated $9.1 million for Alzheimer’s research at the University…
Mega genomes of spruce species decoded
On May 22, 2013, researchers from the Genome Sciences Centre at BC Cancer Agency, the University of British…
Biotechnology | Disease | FDA | Therapeutics
ZymoGenetics received FDA authorization to manufacture the product Thrombin topical (Recombinant)
On Jan. 17, 2008, ZymoGenetics received U.S. Food and Drug Administration (FDA) authorization to manufacture the product Thrombin…